<?xml version="1.0" encoding="UTF-8"?>
<ref id="B23-viruses-11-00322">
 <label>23.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Kam</surname>
    <given-names>Y.W.</given-names>
   </name>
   <name>
    <surname>Simarmata</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Chow</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Her</surname>
    <given-names>Z.</given-names>
   </name>
   <name>
    <surname>Teng</surname>
    <given-names>T.S.</given-names>
   </name>
   <name>
    <surname>Ong</surname>
    <given-names>E.K.S.</given-names>
   </name>
   <name>
    <surname>RÃ©nia</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Leo</surname>
    <given-names>Y.S.</given-names>
   </name>
   <name>
    <surname>Ng</surname>
    <given-names>L.F.P.</given-names>
   </name>
  </person-group>
  <article-title>Early appearance of neutralizing immunoglobulin G3 antibodies is associated with chikungunya virus clearance and long-term clinical protection</article-title>
  <source>J. Infect. Dis.</source>
  <year>2012</year>
  <volume>205</volume>
  <fpage>1147</fpage>
  <lpage>1154</lpage>
  <pub-id pub-id-type="doi">10.1093/infdis/jis033</pub-id>
  <pub-id pub-id-type="pmid">22389226</pub-id>
 </element-citation>
</ref>
